XOMA Royalty (XOMA) Depreciation & Amortization (CF) (2010 - 2026)

XOMA Royalty's (XOMA) quarterly Depreciation & Amortization (CF) came in at $3000.0 in Q1 2026, little changed year-on-year from $3000.0 in Q1 2025, and little changed quarter-over-quarter from $3000.0 in Q4 2025.

XOMA Royalty (XOMA) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

XOMA Royalty has disclosed Depreciation & Amortization (CF) across 17 years of filings, most recently posting $3000.0 for Q1 2026.

  • Depreciation & Amortization (CF) for Q1 2026 came in at $3000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $11000.0 (changed 0.0% YoY), and the FY2025 annual result was $11000.0, up 10.0% from the prior year.
  • Depreciation & Amortization (CF) came in at $3000.0 for Q1 2026 at XOMA Royalty, roughly flat from $3000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $4000.0 in Q3 2022 to a low of $1000.0 in Q2 2022.
  • The 5-year median for Depreciation & Amortization (CF) is $2000.0 (2022), against an average of $2266.7.
  • Across the five-year window, Depreciation & Amortization (CF) plunged 50.0% in 2022 and surged 200.0% in 2024, its largest moves.
  • XOMA Royalty's Depreciation & Amortization (CF) stood at $4000.0 in 2022, then slumped by 75.0% to $1000.0 in 2023, then soared by 100.0% to $2000.0 in 2024, then surged by 50.0% to $3000.0 in 2025, then changed by 0.0% to $3000.0 in 2026.
  • The last three Depreciation & Amortization (CF) figures came in at $3000.0 (Q1 2026), $3000.0 (Q4 2025), and $2000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - 1,395.22
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -1,330.00
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 55.90 Mn
9 Abivax 95.45 Bn 95.45 Bn - 429,663.65
10 XOMA Royalty 5.52 Mn -60.56 Mn - 3,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 3,000.00
Mar 31, 2026 3,000.00
Dec 31, 2025 3,000.00
Dec 31, 2025 3,000.00
Sep 30, 2025 2,000.00
Sep 30, 2025 2,000.00
Jun 30, 2025 3,000.00
Jun 30, 2025 3,000.00
Mar 31, 2025 3,000.00
Mar 31, 2025 3,000.00
Dec 31, 2024 2,000.00
Dec 31, 2024 2,000.00
Sep 30, 2024 3,000.00
Sep 30, 2024 3,000.00
Jun 30, 2024 3,000.00
Jun 30, 2024 3,000.00
Mar 31, 2024 2,000.00
Mar 31, 2024 2,000.00
Dec 31, 2023 1,000.00
Dec 31, 2023 1,000.00